In conclusion, our study demonstrates that Calanquinone A exerts potent antitumor effects against glioblastoma multiforme by inhibiting cell viability, proliferation, and migration through suppression of the STAT3/c-Myc and STAT3/MMP9 signaling pathways. Here, MYC is linked to glioblastoma.